Shanghai Labway Clinical Laboratory Co

Shanghai Labway Clinical Laboratory Co Current Liabilities

The Current Liabilities of Shanghai Labway Clinical Laboratory Co (301060.SZ) as of Nov 2, 2026 is 402.91 M CNY. In the previous year, Current Liabilities was 682.39 M CNY — a change of -40.96% (lower).

Current Liabilities

402.91 MCNY

YoY

-40.96%

Last updated:

Current Liabilities of Shanghai Labway Clinical Laboratory Co is 2025 402.91 M CNY. Current Liabilities of Shanghai Labway Clinical Laboratory Co was 2024 682.39 M CNY. It decreases by -40.96% lower compared to the previous year.

The Shanghai Labway Clinical Laboratory Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
264.86 M CNY
Jan 1, 2019
205.39 M CNY
Jan 1, 2020
259.52 M CNY
Jan 1, 2021
458.31 M CNY
Jan 1, 2022
1.62 B CNY
Jan 1, 2023
884.23 M CNY
Jan 1, 2024
682.39 M CNY
Jan 1, 2025
402.91 M CNY
The Shanghai Labway Clinical Laboratory Co Current Liabilities history
YEARCurrent LiabilitiesYoY
402.91 MCNY-40.96%
682.39 MCNY-22.83%
884.23 MCNY-45.38%
1.62 BCNY+253.23%
458.31 MCNY+76.60%
259.52 MCNY+26.35%
205.39 MCNY-22.45%
264.86 MCNY+30.15%
203.50 MCNY-38.19%
329.25 MCNY+26.39%
260.50 MCNY+11.77%
233.07 MCNY+34.34%
173.50 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Labway Clinical Laboratory Co Stock analysis

What does Shanghai Labway Clinical Laboratory Co do? Shanghai Labway Clinical Laboratory Co., Ltd. generates revenue through medical and pathological examination services, including pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination, and physical and chemical examination. The company also sells in vitro diagnostic instruments, reagents, and related accessories and consumables. Its primary customers are healthcare providers and medical institutions requiring diagnostic services and diagnostic products. The business segments are medical testing services and in vitro diagnostic product sales. The company's medical testing services cater to hospitals and clinics seeking comprehensive diagnostic solutions, while the in vitro diagnostic product sales target healthcare facilities needing equipment and supplies for laboratory operations. These services and products are provided to clients across China, focusing on the healthcare sector's demand for accurate and timely diagnostic capabilities. Shanghai Labway's revenue streams are derived from both service fees for examinations and sales of diagnostic instruments and reagents. The company's offerings align with the growing need for advanced medical diagnostics in China's expanding healthcare market, serving a broad client base within the medical industry. Shanghai Labway Clinical Laboratory Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Labway Clinical Laboratory Co stock

Current Liabilities of Shanghai Labway Clinical Laboratory Co is 402.91 M CNY in 2025.

Current Liabilities of Shanghai Labway Clinical Laboratory Co changed from 682.39 M CNY to 402.91 M CNY, representing a -40.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Shanghai Labway Clinical Laboratory Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Shanghai Labway Clinical Laboratory Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Shanghai Labway Clinical Laboratory Co

All Key Metrics — Shanghai Labway Clinical Laboratory Co